Artemether–lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study

BACKGROUND: Ethiopia has set a goal to eliminate malaria by 2030; Artemether–lumefantrine (AL) is put as one of the cornerstone strategies for uncomplicated plasmodium falciparum malaria treatment. However, only focusing on prescribing of the treatment without assessing patients’ adherence could lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebrekidan, Mekonnen Gebremichael, Gebremedhin, Gebretsadik Berhe, Gebregiorgis, Yosef Sibhatu, Gezehegn, Alefech Addisu, Weldearegay, Kissanet Tesfay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653737/
https://www.ncbi.nlm.nih.gov/pubmed/33168093
http://dx.doi.org/10.1186/s13756-020-00846-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653737/
https://www.ncbi.nlm.nih.gov/pubmed/33168093
http://dx.doi.org/10.1186/s13756-020-00846-y

Ejemplares similares